.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Deloitte
US Department of Justice
Novartis
US Army
Farmers Insurance
Baxter
Accenture
Merck
Federal Trade Commission

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,318,817

« Back to Dashboard

Which drugs does patent 8,318,817 protect, and when does it expire?


Patent 8,318,817 protects OTIPRIO and is included in one NDA.

This patent has one hundred and nineteen patent family members in nineteen countries.

Summary for Patent: 8,318,817

Title:Controlled release antimicrobial compositions and methods for the treatment of otic disorders
Abstract: Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).
Inventor(s): Lichter; Jay (Rancho Santa Fe, CA), Lebel; Carl (Malibu, CA), Piu; Fabrice (San Diego, CA), Ye; Qiang (San Diego, CA), Dellamary; Luis A. (San Marcos, CA), Trammel; Andrew M. (Olathe, KS), Harris; Jeffrey P. (La Jolla, CA)
Assignee: Otonomy, Inc. (San Diego, CA) The Regents of the University of California (Oakland, CA)
Application Number:12/506,127
Patent Claim Types:
see list of patent claims
Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Otonomy IncOTIPRIOciprofloxacinINJECTABLE, SUSPENSION;OTIC207986-001Dec 10, 2015RXYesYes► Subscribe► SubscribeTREATMENT OF OTIC INFECTION OR INFLAMMATION► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,318,817

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,333,171Controlled-release CNS modulating compositions and methods for the treatment of otic disorders► Subscribe
9,205,048Controlled release antimicrobial compositions and methods for the treatment of otic disorders► Subscribe
8,648,119Controlled release immunomodulator compositions and methods for the treatment of otic disorders► Subscribe
9,511,020Controlled release corticosteroid compositions and methods for the treatment of otic disorders► Subscribe
9,066,855Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders► Subscribe
8,828,980Controlled release corticosteroid compositions and methods for the treatment of otic disorders► Subscribe
8,030,297Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders► Subscribe
9,744,126Controlled release corticosteroid compositions and methods for the treatment of otic disorders► Subscribe
8,658,626Controlled release corticosteroid compositions and methods for the treatment of otic disorders► Subscribe
9,233,068Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,318,817

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina071388► Subscribe
Argentina072253► Subscribe
Argentina072828► Subscribe
Australia2009239429► Subscribe
Australia2009246870► Subscribe
Australia2009271129► Subscribe
Australia2009274137► Subscribe
Australia2009274229► Subscribe
Australia2009330458► Subscribe
BrazilPI0915770► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Fish and Richardson
Mallinckrodt
Healthtrust
Chubb
Julphar
Merck
Covington
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot